Exploiting the conformational complexity of GPCRs to innovate drug discovery

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. Confo Therapeutics employs its proprietary CONFO® technology to lock inherently unstable functional conformations of GPCRs as a superior starting point for drug discovery. CONFO® body-stabilized active state conformations of these receptors expose previously inaccessible structural features empowering the discovery of novel agonists for better therapeutic intervention.

Research
and Development

News

CEO appointment

07.09.2016
download

New CSO Dr. Christel Menet

10.05.2016
download

Financial closing

02.02.2016
download

Company incorporation

24.06.2015
download

Pleinlaan 2
Building E, 7th Floor, Room E7.6
1050 Brussels
Belgium

info@confotherapeutics.com

>> view on google maps

Investors

Founding institutes

Investors